Latest Regulatory Approvals News

Pacific Smiles Group has agreed to an unconditional $2.20 per share cash takeover offer from its majority shareholder Genesis Bidco, representing a 37.5% premium. The Independent Board Committee recommends shareholders accept the offer, pending no superior proposal and ongoing fairness confirmation.

ABx Group’s subsidiary ABx3 has received a $2.7 million investment from Good Importing International, granting GII 70% ownership to develop the Sunrise Bauxite Project in Queensland. This funding kickstarts a 12–24 month program targeting regulatory approvals and mine planning, with further investment options on the horizon.

Moab Minerals is set to acquire full ownership of Imbas Mining, unlocking rights to earn up to 80% of the Sasare Gold and Copper Project in Zambia, a site with notable historic gold production and promising copper targets. The acquisition paves the way for an initial exploration campaign targeting both gold and copper mineralisation.

EVE Health Group has raised $1.1 million to accelerate the commercial rollout of its innovative pharmaceutical products Dyspro and Libbo, signaling strong investor confidence in its growth strategy.

Elders Limited has secured regulatory approval to acquire Delta Agribusiness, subject to divesting six Western Australian branches, while maintaining a positive outlook for FY25 earnings.

The ACCC has approved Elders Limited’s acquisition of Delta Agribusiness, contingent on Elders divesting six Delta retail stores in Western Australia to preserve local competition.

NH3 Clean Energy updates investors on the WAH2 clean ammonia project, highlighting strong market potential, strategic partnerships, and robust project economics as it moves toward a Final Investment Decision.

PainChek Limited has achieved a landmark FDA De Novo classification for its PainChek Adult App, positioning it as the first regulated medical device for pain assessment in the US aged care sector and opening a $100 million annual market opportunity.

Power Minerals Limited has secured an option to acquire the Gamma Heavy Rare Earths Project in California, adjacent to the Mountain Pass Mine, backed by a $4.1 million placement to accelerate exploration.

Adamantem Capital Management has completed its due diligence on Apiam Animal Health and extended its exclusivity period to negotiate a potential $0.87 per share acquisition. The deal remains subject to approvals and binding agreements.

Eastern Metals Limited has entered a definitive agreement to acquire Raptor Resources Limited, adding significant copper and gold assets in Canada and Western Australia, alongside a planned capital raise to fund exploration and ASX reinstatement.

Dimerix’s latest PARASOL collaboration analysis reinforces proteinuria as a pivotal endpoint in their Phase 3 FSGS trial, setting the stage for FDA discussions on accelerated approval pathways.